Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 2
2021 3
2022 3
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Capturing human trophoblast development with naive pluripotent stem cells in vitro.
Io S, Kabata M, Iemura Y, Semi K, Morone N, Minagawa A, Wang B, Okamoto I, Nakamura T, Kojima Y, Iwatani C, Tsuchiya H, Kaswandy B, Kondoh E, Kaneko S, Woltjen K, Saitou M, Yamamoto T, Mandai M, Takashima Y. Io S, et al. Among authors: kabata m. Cell Stem Cell. 2021 Jun 3;28(6):1023-1039.e13. doi: 10.1016/j.stem.2021.03.013. Epub 2021 Apr 7. Cell Stem Cell. 2021. PMID: 33831365 Free article.
Hypoblast from human pluripotent stem cells regulates epiblast development.
Okubo T, Rivron N, Kabata M, Masaki H, Kishimoto K, Semi K, Nakajima-Koyama M, Kunitomi H, Kaswandy B, Sato H, Nakauchi H, Woltjen K, Saitou M, Sasaki E, Yamamoto T, Takashima Y. Okubo T, et al. Among authors: kabata m. Nature. 2024 Feb;626(7998):357-366. doi: 10.1038/s41586-023-06871-2. Epub 2023 Dec 5. Nature. 2024. PMID: 38052228 Free PMC article.
MYCL-mediated reprogramming expands pancreatic insulin-producing cells.
Hirano M, So Y, Tsunekawa S, Kabata M, Ohta S, Sagara H, Sankoda N, Taguchi J, Yamada Y, Ukai T, Kato M, Nakamura J, Ozawa M, Yamamoto T, Yamada Y. Hirano M, et al. Among authors: kabata m. Nat Metab. 2022 Feb;4(2):254-268. doi: 10.1038/s42255-022-00530-y. Epub 2022 Feb 10. Nat Metab. 2022. PMID: 35145326
The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targets.
Ito K, Nagata K, Ohta S, Matsuda Y, Ukai T, Yasuda I, Ota A, Kobayashi R, Kabata M, Sankoda N, Maeda T, Woltjen K, Yang L, Maruyama R, Katayama R, Yamamoto T, Yamada Y. Ito K, et al. Among authors: kabata m. Cell Rep. 2022 Apr 26;39(4):110721. doi: 10.1016/j.celrep.2022.110721. Cell Rep. 2022. PMID: 35476996 Free article.
In vivo reprogramming drives Kras-induced cancer development.
Shibata H, Komura S, Yamada Y, Sankoda N, Tanaka A, Ukai T, Kabata M, Sakurai S, Kuze B, Woltjen K, Haga H, Ito Y, Kawaguchi Y, Yamamoto T, Yamada Y. Shibata H, et al. Among authors: kabata m. Nat Commun. 2018 May 25;9(1):2081. doi: 10.1038/s41467-018-04449-5. Nat Commun. 2018. PMID: 29802314 Free PMC article.
Vasculature-driven stem cell population coordinates tissue scaling in dynamic organs.
Ichijo R, Kabata M, Kidoya H, Muramatsu F, Ishibashi R, Abe K, Tsutsui K, Kubo H, Iizuka Y, Kitano S, Miyachi H, Kubota Y, Fujiwara H, Sada A, Yamamoto T, Toyoshima F. Ichijo R, et al. Among authors: kabata m. Sci Adv. 2021 Feb 10;7(7):eabd2575. doi: 10.1126/sciadv.abd2575. Print 2021 Feb. Sci Adv. 2021. PMID: 33568475 Free PMC article.
DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency.
Taguchi J, Shibata H, Kabata M, Kato M, Fukuda K, Tanaka A, Ohta S, Ukai T, Mitsunaga K, Yamada Y, Nagaoka SI, Yamazawa S, Ohnishi K, Woltjen K, Ushiku T, Ozawa M, Saitou M, Shinkai Y, Yamamoto T, Yamada Y. Taguchi J, et al. Among authors: kabata m. Nat Commun. 2021 Aug 19;12(1):5041. doi: 10.1038/s41467-021-25249-4. Nat Commun. 2021. PMID: 34413299 Free PMC article.
16 results